Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2026-01-04 @ 11:12 PM
Study NCT ID:
NCT03936894
Status:
UNKNOWN
Last Update Posted:
2023-09-21
First Post:
2019-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy
Sponsor:
Children's National Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-29
First Submit QC Date:
None
Study First Post Date:
2019-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-19
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL